Abstract
A salivary fistula is a relatively uncommon but troublesome complication after parotid surgery. Most cases are self-limiting and respond well to conservative therapy (compression dressings). However, this treatment may require weeks before its effect becomes evident. We present the first report of direct administration of botulinum toxin type A as an effective primary treatment for an acute salivary fistula after parotid surgery, in the absence of other, more conservative treatment. A 47-year-old man with a 7-day history of sore throat was found to have a parapharyngeal tumor originating from the deep lobe of the parotid gland. He underwent tumor removal via a trans-paroticocervical approach. However, on postoperative day 7, the patient was noted to have massive salivary discharge from the surgical incision during a meal. We administered a transcutaneous botulinum toxin type A injection without a pressure dressing. One day after the injection, the salivary discharge from the incision line disappeared completely and there was no evidence of recurrent sialorrhea in the 6 months following the procedure. This report suggests that the injection of botulinum toxin type A is a highly effective and relatively safe primary method of treatment for an acute postparotidectomy salivary fistula, and not merely an alternative to more conservative therapy.
Similar content being viewed by others
References
Christie A (1987) Infectious disease. Churchill Livingstone, London
Landau R, Stewart M (1985) Conservative management of posttraumatic parotid fistulae and sialoceles: a prospective study. Br J Surg 72:42–44
Laskawi R, Drobik C, Schonebeck C (1998) Up-to-date report of botulinum toxin type A treatment in patients with gustatory sweating (Frey’s syndrome). Laryngoscope 108:381–384
Laskawi R, Schott T, Mirzaie-Petti M, Schroeder M (1996) Surgical management of pleomorphic adenomas of the parotid gland: a follow up study of three months. J Oral Maxillofac Surg 54:1176–1179
Marchese-Ragona R, Marioni G, Restivo DA, Staffieri A (2006) The role of botulinum toxin in postparotidectomy fistula treatment. A technical note. Am J Otolaryngol 27:221–224
Parekh D, Glezerson G, Stewart M, Esser J, Lawson HH (1989) Post-traumatic parotid fistulae and sialoceles. A prospective study of conservative management in 51 cases. Ann Surg 209:105–111
Tugnoli V, Eleopra R, Montecucco C, DeGrandis D (1997) The therapeutic use of botulinum toxin. Expert Opin Investig Drugs 6:1383–1394
Vargas H, Galati LT, Parnes SM (2000) A pilot study evaluating the treatment of postparotidectomy sialoceles with botulinum toxin type A. Arch Otolaryngol Head Neck Surg 126:421–424
von Lindern JJ, Niederhagen B, Appel T, Berge S, Reich RH (2002) New prospects in the treatment of traumatic and postoperative parotid fistulas with type A botulinum toxin. Plast Reconstr Surg 109:2443–2445
Wax M, Tarshis L (1991) Post-parotidectomy fistula. J Otolaryngol 20:10–13
Acknowledgments
This work was supported by the second phase of the Brain Korea 21 Project.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lim, Y.C., Choi, E.C. Treatment of an acute salivary fistula after parotid surgery: botulinum toxin type A injection as primary treatment. Eur Arch Otorhinolaryngol 265, 243–245 (2008). https://doi.org/10.1007/s00405-007-0418-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00405-007-0418-6